The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation

Katsuya Nakata, Akiyoshi Takami, J. Luis Espinoza, Keitaro Matsuo, Yasuo Morishima, Makoto Onizuka, Takahiro Fukuda, Yoshihisa Kodera, Hideki Akiyama, Koichi Miyamura, Takehiko Mori, Shinji Nakao

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

CXCL10 is a chemoattractant for immune cells that is involved in several immune-inflammatory disorders. This study retrospectively examined the impact of a single nucleotide variation (rs3921, +. 1642C>G) in the CXCL10 gene on transplant outcomes in a cohort of 652 patients who underwent unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies. The recipient C/G or G/G genotype was found to be associated with a significantly better 5-year overall survival (OS) rate and a lower transplant-related mortality (TRM) rate than the recipient C/C genotype. The recipient C/G or G/G genotype also predicted a reduced incidence of death due to organ failure. The multivariate analysis showed the recipient C/G or G/G genotype to exhibit statistical trends toward beneficial effects on OS but not on TRM. CXCL10 genotyping could therefore be useful in predicting prognoses and creating therapeutic strategies for improving the final outcomes of patients who undergo allogeneic BMT.

Original languageEnglish
Pages (from-to)104-111
Number of pages8
JournalClinical Immunology
Volume146
Issue number2
DOIs
Publication statusPublished - 2013 Feb

Fingerprint

Bone Marrow Transplantation
Genotype
Survival
Transplants
Mortality
Chemotactic Factors
Immune System Diseases
Homologous Transplantation
Hematologic Neoplasms
Multivariate Analysis
Survival Rate
Nucleotides
Incidence
Genes
Therapeutics

Keywords

  • Bone marrow transplantation;
  • Chemokine;
  • CXCL10;
  • Organ failure
  • Single nucleotide variation;
  • Unrelated donor;

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation. / Nakata, Katsuya; Takami, Akiyoshi; Espinoza, J. Luis; Matsuo, Keitaro; Morishima, Yasuo; Onizuka, Makoto; Fukuda, Takahiro; Kodera, Yoshihisa; Akiyama, Hideki; Miyamura, Koichi; Mori, Takehiko; Nakao, Shinji.

In: Clinical Immunology, Vol. 146, No. 2, 02.2013, p. 104-111.

Research output: Contribution to journalArticle

Nakata, K, Takami, A, Espinoza, JL, Matsuo, K, Morishima, Y, Onizuka, M, Fukuda, T, Kodera, Y, Akiyama, H, Miyamura, K, Mori, T & Nakao, S 2013, 'The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation', Clinical Immunology, vol. 146, no. 2, pp. 104-111. https://doi.org/10.1016/j.clim.2012.11.009
Nakata, Katsuya ; Takami, Akiyoshi ; Espinoza, J. Luis ; Matsuo, Keitaro ; Morishima, Yasuo ; Onizuka, Makoto ; Fukuda, Takahiro ; Kodera, Yoshihisa ; Akiyama, Hideki ; Miyamura, Koichi ; Mori, Takehiko ; Nakao, Shinji. / The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation. In: Clinical Immunology. 2013 ; Vol. 146, No. 2. pp. 104-111.
@article{630a4223be7b4112b298472def0d04a5,
title = "The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation",
abstract = "CXCL10 is a chemoattractant for immune cells that is involved in several immune-inflammatory disorders. This study retrospectively examined the impact of a single nucleotide variation (rs3921, +. 1642C>G) in the CXCL10 gene on transplant outcomes in a cohort of 652 patients who underwent unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies. The recipient C/G or G/G genotype was found to be associated with a significantly better 5-year overall survival (OS) rate and a lower transplant-related mortality (TRM) rate than the recipient C/C genotype. The recipient C/G or G/G genotype also predicted a reduced incidence of death due to organ failure. The multivariate analysis showed the recipient C/G or G/G genotype to exhibit statistical trends toward beneficial effects on OS but not on TRM. CXCL10 genotyping could therefore be useful in predicting prognoses and creating therapeutic strategies for improving the final outcomes of patients who undergo allogeneic BMT.",
keywords = "Bone marrow transplantation;, Chemokine;, CXCL10;, Organ failure, Single nucleotide variation;, Unrelated donor;",
author = "Katsuya Nakata and Akiyoshi Takami and Espinoza, {J. Luis} and Keitaro Matsuo and Yasuo Morishima and Makoto Onizuka and Takahiro Fukuda and Yoshihisa Kodera and Hideki Akiyama and Koichi Miyamura and Takehiko Mori and Shinji Nakao",
year = "2013",
month = "2",
doi = "10.1016/j.clim.2012.11.009",
language = "English",
volume = "146",
pages = "104--111",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The recipient CXCL10 +1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation

AU - Nakata, Katsuya

AU - Takami, Akiyoshi

AU - Espinoza, J. Luis

AU - Matsuo, Keitaro

AU - Morishima, Yasuo

AU - Onizuka, Makoto

AU - Fukuda, Takahiro

AU - Kodera, Yoshihisa

AU - Akiyama, Hideki

AU - Miyamura, Koichi

AU - Mori, Takehiko

AU - Nakao, Shinji

PY - 2013/2

Y1 - 2013/2

N2 - CXCL10 is a chemoattractant for immune cells that is involved in several immune-inflammatory disorders. This study retrospectively examined the impact of a single nucleotide variation (rs3921, +. 1642C>G) in the CXCL10 gene on transplant outcomes in a cohort of 652 patients who underwent unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies. The recipient C/G or G/G genotype was found to be associated with a significantly better 5-year overall survival (OS) rate and a lower transplant-related mortality (TRM) rate than the recipient C/C genotype. The recipient C/G or G/G genotype also predicted a reduced incidence of death due to organ failure. The multivariate analysis showed the recipient C/G or G/G genotype to exhibit statistical trends toward beneficial effects on OS but not on TRM. CXCL10 genotyping could therefore be useful in predicting prognoses and creating therapeutic strategies for improving the final outcomes of patients who undergo allogeneic BMT.

AB - CXCL10 is a chemoattractant for immune cells that is involved in several immune-inflammatory disorders. This study retrospectively examined the impact of a single nucleotide variation (rs3921, +. 1642C>G) in the CXCL10 gene on transplant outcomes in a cohort of 652 patients who underwent unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies. The recipient C/G or G/G genotype was found to be associated with a significantly better 5-year overall survival (OS) rate and a lower transplant-related mortality (TRM) rate than the recipient C/C genotype. The recipient C/G or G/G genotype also predicted a reduced incidence of death due to organ failure. The multivariate analysis showed the recipient C/G or G/G genotype to exhibit statistical trends toward beneficial effects on OS but not on TRM. CXCL10 genotyping could therefore be useful in predicting prognoses and creating therapeutic strategies for improving the final outcomes of patients who undergo allogeneic BMT.

KW - Bone marrow transplantation;

KW - Chemokine;

KW - CXCL10;

KW - Organ failure

KW - Single nucleotide variation;

KW - Unrelated donor;

UR - http://www.scopus.com/inward/record.url?scp=84871859565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871859565&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2012.11.009

DO - 10.1016/j.clim.2012.11.009

M3 - Article

C2 - 23291247

AN - SCOPUS:84871859565

VL - 146

SP - 104

EP - 111

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -